We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

170 hedge funds and large institutions have $818M invested in Natus Medical Inc in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 57 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more call options, than puts

Call options by funds: $1.89M | Put options by funds: $793K

100% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 14

9% more funds holding

Funds holding: 156170 (+14)

4% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 55

0% less capital invested

Capital invested by funds: $819M → $818M (-$539K)

Holders
170
Holders Change
+14
Holders Change %
+8.97%
% of All Funds
2.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
57
Reduced
55
Closed
14
Calls
$1.89M
Puts
$793K
Net Calls
+$1.09M
Net Calls Change
+$2.07M
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
26
Invesco
Georgia
$6.04M -$10.7M -392,489 -63%
Nordea Investment Management
27
Nordea Investment Management
Sweden
$5.62M +$535K +19,656 +10%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$5.37M -$6.28M -230,900 -53%
Morgan Stanley
29
Morgan Stanley
New York
$5.22M -$2.79M -102,459 -34%
RA
30
Royce & Associates
New York
$4.74M -$172K -6,318 -3%
CIM
31
Confluence Investment Management
Missouri
$4.67M +$116K +4,256 +2%
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$4.31M -$2.74M -100,827 -38%
AllianceBernstein
33
AllianceBernstein
Tennessee
$4.14M +$571K +20,978 +15%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$3.63M -$560K -20,589 -13%
PPA
35
Parametric Portfolio Associates
Washington
$3.6M +$314K +11,537 +9%
Bank of America
36
Bank of America
North Carolina
$3.58M -$1.74M -63,967 -32%
GC
37
Globeflex Capital
California
$3.33M +$3.65K +134 +0.1%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$3.04M -$13.5K -497 -0.4%
RCM
39
Rutabaga Capital Management
Massachusetts
$3.02M
BCC
40
Bridge City Capital
Oregon
$2.78M -$96K -3,530 -3%
FAM
41
Fenimore Asset Management
New York
$2.61M -$6.55M -240,583 -71%
DCM
42
DAFNA Capital Management
California
$2.48M
Deutsche Bank
43
Deutsche Bank
Germany
$2.47M -$151K -5,540 -5%
Two Sigma Investments
44
Two Sigma Investments
New York
$2.45M +$1.03M +37,890 +67%
Legal & General Group
45
Legal & General Group
United Kingdom
$2.29M -$615K -22,606 -20%
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.94M -$73.5K -2,700 -3%
Citadel Advisors
47
Citadel Advisors
Florida
$1.91M +$1.29M +47,378 +181%
New York State Teachers Retirement System (NYSTRS)
48
New York State Teachers Retirement System (NYSTRS)
New York
$1.9M
CGFI
49
Cypress Growth Fund III
California
$1.82M
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.81M

NTUS Hedge Fund Activity: Q2 2021 in Review

170 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2021, worth a combined $818M — down 0.07% from $819M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NTUS positions and 14 closed out — a net gain of 14 holders — while 57 added to existing stakes and 55 trimmed.

The largest buyer was Tributary Capital Management, opening a new position worth an estimated $11.1M. The largest seller was Invesco, cutting an estimated $10.7M.

  • 170 institutional investors held Natus Medical Inc (NTUS) as of Q2 2021, up from 156 in Q1 2021.
  • Funds reported $818M of Natus Medical Inc stock for Q2 2021, down 0.07% quarter-over-quarter.
  • 28 funds opened new Natus Medical Inc positions in Q2 2021 and 14 closed out, a net change of +14 holders.
  • The largest Natus Medical Inc buyer in Q2 2021 was Tributary Capital Management, an estimated $11.1M added.
  • The largest Natus Medical Inc seller in Q2 2021 was Invesco, an estimated $10.7M sold.

Based on aggregated 13F filings for Q2 2021.